Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q2 2026)
27,121
Value
$2.31M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CYTK by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202627,121$2.31M<0.1%−656−2.4%ReducedHolders
Q1 202627,777$1.83M<0.1%−4,442−13.8%ReducedHolders
Q4 202532,219$2.05M<0.1%+2,889+9.8%AddedHolders
Q3 202529,330$1.61M<0.1%−4,380−13.0%ReducedHolders
Q2 202533,710$1.11M<0.1%−1,405−4.0%ReducedHolders
Q1 202535,115$1.41M<0.1%−8,184−18.9%ReducedHolders
Q4 202443,299$2.04M<0.1%+9,620+28.6%AddedHolders
Q3 202433,679$1.78M<0.1%+7,112+26.8%AddedHolders
Q2 202426,567$1.44M<0.1%−2,600−8.9%ReducedHolders
Q1 202429,167$2.04M<0.1%+5,313+22.3%AddedHolders
Q4 202323,854$1.99M<0.1%+3,342+16.3%AddedHolders
Q3 202320,512$604.3K<0.1%−287−1.4%ReducedHolders
Q2 202320,799$678.5K<0.1%+1,993+10.6%AddedHolders
Q1 202318,806$661.8K<0.1%−2,343−11.1%ReducedHolders
Q4 202221,149$969.0K<0.1%+1,615+8.3%AddedHolders
Q3 202219,534$947.0K<0.1%+1,192+6.5%AddedHolders
Q2 202218,342$721.0K<0.1%−8,232−31.0%ReducedHolders
Q1 202226,574$979.0K<0.1%−5,188−16.3%ReducedHolders
Q4 202131,762$1.45M<0.1%+1,601+5.3%AddedHolders
Q3 202130,161$1.08M<0.1%−2,347−7.2%ReducedHolders
Q2 202132,508$643.0K<0.1%+2,815+9.5%AddedHolders
Q1 202129,693$691.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.